CLINICAL_TRIALS
trial_result
· 2025-06-27
Clinical Trial Update: Temozolomide Chronotherapy for High Grade Glioma [Phase 2]
Summary
Phase 2 trial of temozolomide chronotherapy for high-grade glioma, including glioblastoma, has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Washington University School of Medicine | Conditions: Glioma, Glioblastoma Multiforme | Phase 2 | Status: COMPLETED | Results posted: 2025-06-27